Search research articles
Contact Us
Filters
Showing results (51-60 of 108) with videos related to
Page
of 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2007
Mycobacterium bovis bacillus Calmette-Guérin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages
Hafid Soualhine, Ala-Eddine Deghmane, Jim Sun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 3, 2018
Unusual Initial Abdominal Presentations of Invasive Meningococcal Disease
Tamazoust Guiddir, Marion Gros, Eva Hong, et al.
BMC Infectious Diseases
|
July 31, 2021
Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules
Eva Hong, Aude Terrade, Mélanie Denizon, et al.
BMC Microbiology
|
August 16, 2025
Inactivation of the porB gene reduces the virulence of Neisseria meningitidis in transgenic mice
Cecilia Klanger, Ala-Eddine Deghmane, Lorraine Eriksson, et al.
Steroids
|
May 14, 2018
Analysis of the impact of corticosteroids adjuvant treatment during experimental invasive meningococcal infection in mice
Michaël Levy, Ala-Eddine Deghmane, Myriam Aouiti-Trabelsi, et al.
Plos One
|
September 23, 2016
The Phosphocarrier Protein HPr Contributes to Meningococcal Survival during Infection
Ana Antunes, Meriem Derkaoui, Aude Terrade, et al.
Plos Pathogens
|
August 5, 2015
Hyperinvasive Meningococci Induce Intra-nuclear Cleavage of the NF-κB Protein p65/RelA by Meningococcal IgA Protease
Anissa Besbes, Salomé Le Goff, Ana Antunes, et al.
Vaccine
|
June 5, 2012
Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac
François Caron, Valérie Delbos, Estelle Houivet, et al.
BMC Microbiology
|
April 17, 2020
Difference in virulence between Neisseria meningitidis serogroups W and Y in transgenic mice
Lorraine Eriksson, Bianca Stenmark, Ala-Eddine Deghmane, et al.
Vaccine
|
December 25, 2012
Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
Eva Hong, Marzia Monica Giuliani, Ala-Eddine Deghmane, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 108) with videos related to
Sort By:
Page
of 11
Journal of Immunology (Baltimore, Md. : 1950)
|
October 4, 2007
Mycobacterium bovis bacillus Calmette-Guérin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages
Hafid Soualhine, Ala-Eddine Deghmane, Jim Sun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 3, 2018
Unusual Initial Abdominal Presentations of Invasive Meningococcal Disease
Tamazoust Guiddir, Marion Gros, Eva Hong, et al.
BMC Infectious Diseases
|
July 31, 2021
Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules
Eva Hong, Aude Terrade, Mélanie Denizon, et al.
BMC Microbiology
|
August 16, 2025
Inactivation of the porB gene reduces the virulence of Neisseria meningitidis in transgenic mice
Cecilia Klanger, Ala-Eddine Deghmane, Lorraine Eriksson, et al.
Steroids
|
May 14, 2018
Analysis of the impact of corticosteroids adjuvant treatment during experimental invasive meningococcal infection in mice
Michaël Levy, Ala-Eddine Deghmane, Myriam Aouiti-Trabelsi, et al.
Plos One
|
September 23, 2016
The Phosphocarrier Protein HPr Contributes to Meningococcal Survival during Infection
Ana Antunes, Meriem Derkaoui, Aude Terrade, et al.
Plos Pathogens
|
August 5, 2015
Hyperinvasive Meningococci Induce Intra-nuclear Cleavage of the NF-κB Protein p65/RelA by Meningococcal IgA Protease
Anissa Besbes, Salomé Le Goff, Ana Antunes, et al.
Vaccine
|
June 5, 2012
Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac
François Caron, Valérie Delbos, Estelle Houivet, et al.
BMC Microbiology
|
April 17, 2020
Difference in virulence between Neisseria meningitidis serogroups W and Y in transgenic mice
Lorraine Eriksson, Bianca Stenmark, Ala-Eddine Deghmane, et al.
Vaccine
|
December 25, 2012
Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
Eva Hong, Marzia Monica Giuliani, Ala-Eddine Deghmane, et al.
Page
of 11